Literature DB >> 24656964

Exploiting gut bacteriophages for human health.

Marion Dalmasso1, Colin Hill2, R Paul Ross3.   

Abstract

The human gut contains approximately 10(15) bacteriophages (the 'phageome'), probably the richest concentration of biological entities on earth. Mining and exploiting these potential 'agents of change' is an attractive prospect. For many years, phages have been used to treat bacterial infections in humans and more recently have been approved to reduce pathogens in the food chain. Phages have also been studied as drug or vaccine delivery vectors to help treat and prevent diseases such as cancer and chronic neurodegenerative conditions. Individual phageomes vary depending on age and health, thus providing a useful biomarker of human health as well as suggesting potential interventions targeted at the gut microbiota.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bacteriophage; human health; phage therapy; phageome

Mesh:

Substances:

Year:  2014        PMID: 24656964     DOI: 10.1016/j.tim.2014.02.010

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  60 in total

Review 1.  Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.

Authors:  Janka Babickova; Roman Gardlik
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

2.  Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls.

Authors:  Robert H Yolken; Emily G Severance; Sarven Sabunciyan; Kristin L Gressitt; Ou Chen; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Lucy A B Schweinfurth; Christina L G Savage; Maria Banis; Sunil Khushalani; Faith B Dickerson
Journal:  Schizophr Bull       Date:  2015-02-09       Impact factor: 9.306

Review 3.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 4.  Gut microbiota impact on stroke outcome: Fad or fact?

Authors:  Katarzyna Winek; Andreas Meisel; Ulrich Dirnagl
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

5.  An Early History of Phage Therapy in the United States: Is it Time to Reconsider?

Authors:  Vijay H Aswani; Sanjay K Shukla
Journal:  Clin Med Res       Date:  2021-06

Review 6.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

7.  Multiple mechanisms drive phage infection efficiency in nearly identical hosts.

Authors:  Cristina Howard-Varona; Katherine R Hargreaves; Natalie E Solonenko; Lye Meng Markillie; Richard Allen White; Heather M Brewer; Charles Ansong; Galya Orr; Joshua N Adkins; Matthew B Sullivan
Journal:  ISME J       Date:  2018-03-22       Impact factor: 10.302

8.  Intestinal Microbiome and Metal Toxicity.

Authors:  Senait Assefa; Gerwald Köhler
Journal:  Curr Opin Toxicol       Date:  2019-09-30

Review 9.  Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Authors:  Justin D Glenn; Ellen M Mowry
Journal:  J Interferon Cytokine Res       Date:  2016-05-04       Impact factor: 2.607

Review 10.  Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.

Authors:  Alexander S Zevin; Lyle McKinnon; Adam Burgener; Nichole R Klatt
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.